Peter Kaiser
Chief Development Officer at Ocular Therapeutix, Inc (OCUL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $293K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | OCULOcular Therapeutix, Inc | Sell Plan | 9,990254,388 held (−4%) | $7.05 | $70K | +7.0% |
| Aug 26SEC | OCULOcular Therapeutix, Inc | Sell Plan | 3,035264,378 held (−1%) | $10.77 | $33K | -30.0% |
| May 28SEC | OCULOcular Therapeutix, Inc | Sell Plan | 2,967266,141 held (−1%) | $8.20 | $24K | -8.0% |
| Feb 25SEC | OCULOcular Therapeutix, Inc | Sell Plan | 2,810269,108 held (−1%) | $8.28 | $23K | -8.9% |
| Nov 26SEC | OCULOcular Therapeutix, Inc | Sell Plan | 3,007191,433 held (−2%) | $12.02 | $36K | -37.3% |
| Oct 6SEC | OCULOcular Therapeutix, Inc | Sell Plan | 9,653194,440 held (−5%) | $11.03 | $106K | -31.6% |
- Sell
Chief Development Officer Peter Kaiser sold $70K of OCUL at $7.05 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Peter Kaiser sold $33K of OCUL at $10.77 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Peter Kaiser sold $24K of OCUL at $8.20 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Peter Kaiser sold $23K of OCUL at $8.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Peter Kaiser sold $36K of OCUL at $12.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Peter Kaiser sold $106K of OCUL at $11.03 — pre-scheduled 10b5-1 plan sale.